Targeting the NAD(+)-PARP1-XRCC1 axis in ALS.

Ibrahim M, Hossain MS, Ooi L, Hasan MM, Ahsan S, Salem AK, Piazza GA, Feng X, Ahsan F

DOI: 10.1016/j.molmed.2026.04.004
Published: 2026 May 4
Container: Trends in molecular medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.molmed.2026.04.004,
  title = {Targeting the NAD(+)-PARP1-XRCC1 axis in ALS.},
  author = {Ibrahim M and Hossain MS and Ooi L and Hasan MM and Ahsan S and Salem AK and Piazza GA and Feng X and Ahsan F},
  year = {2026},
  journal = {Trends in molecular medicine},
  doi = {10.1016/j.molmed.2026.04.004},
  url = {https://doi.org/10.1016/j.molmed.2026.04.004}
}

RIS

TY  - JOUR
TI  - Targeting the NAD(+)-PARP1-XRCC1 axis in ALS.
AU  - Ibrahim M
AU  - Hossain MS
AU  - Ooi L
AU  - Hasan MM
AU  - Ahsan S
AU  - Salem AK
AU  - Piazza GA
AU  - Feng X
AU  - Ahsan F
PY  - 2026
JO  - Trends in molecular medicine
DO  - 10.1016/j.molmed.2026.04.004
UR  - https://doi.org/10.1016/j.molmed.2026.04.004
ER  -

APA

M, I., MS, H., L, O., MM, H., S, A., AK, S., GA, P., X, F., & F, A. (2026). Targeting the NAD(+)-PARP1-XRCC1 axis in ALS.. Trends in molecular medicine. https://doi.org/10.1016/j.molmed.2026.04.004

Source records

pubmed · retrieved 2026-09-26T14:11:37.984Z